Cantor Fitzgerald predicts a short-term market rally but warns of bearish trends ahead. Learn more information here.

Research analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for shares of Belite Bio in a research note issued on Tuesday, March 18th. Cantor Fitzgerald analyst J. Kim now ...

Meeting to be held in San Francisco on March 31 hosted by Cantor Fitzgerald.Light Up your Portfolio with Spark:Easily identify stocks' risks ...

Protara Therapeutics, Inc. (NASDAQ:TARA – Free Report) – Stock analysts at Cantor Fitzgerald dropped their FY2025 EPS estimates for Protara Therapeutics in a research note issued on Thursday ...

Wendy Williams' health care advocate, Ginalisa Monterroso, tells PEOPLE the former talk show host is looking forward to ...

On Monday, Cantor Fitzgerald reaffirmed its Overweight rating on Rocket Pharmaceuticals (NASDAQ:RCKT) with a steady price target of $50.00. Following a webinar with the company’s management ...

On Tuesday, Cantor Fitzgerald reiterated its Overweight rating on Meta Platforms Inc. (NASDAQ:META) with a price target of $790.00, well above the current trading price of $618.85. The firm’s ...

Friday - Summit Therapeutics plc (NASDAQ:SMMT) stock received a new Overweight rating from Cantor Fitzgerald, signaling a positive outlook from the firm. The coverage initiation by Cantor Fitzgerald ...

Howard Lutnick is the U.S. Secretary of Commerce and the former CEO of Cantor Fitzgerald. © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site ...

On Monday, Cantor Fitzgerald analyst Andres Sheppard reaffirmed an Overweight rating with a $10.00 price target on shares of Aurora Innovation Inc (NASDAQ: NASDAQ:AUR), expressing confidence in the ...